Skip to main content
Premium Trial:

Request an Annual Quote

Vanderbilt to Lead $4M PGx Project to Identify HIV Drug Response Markers

NEW YORK (GenomeWeb News) – The National Institute of Allergy and Infectious Diseases has granted just over $4 million to a Vanderbilt University-led study to identify genetic variations that may predict how individuals will respond to HIV therapies.
 
Researchers will use the five-year grant to identify genetic markers that can predict both efficacy and toxicity of frequently prescribed HIV medications, David Haas, director of the Vanderbilt AIDS Clinical Trials Program and principal investigator on the project, explained in a statement.
 
Under the program, called “Pharmacogenomics of HIV Therapy,” Vanderbilt Medical Center will receive $2.4 million; Harvard University’s School of Public Health will receive $368,000; Massachusetts General Hospital will get nearly $1.1 million; $186,000 will go to researchers at Cornell University/Weill Cornell Medical College; and the University of Western Ontario will receive $23,000.
 
The project will use DNA samples and data from HIV-infected patients from clinical trials in Haiti and in South Africa and will focus on genes that are involved in drug metabolism and transport.
 
Another goal of the project is to assess the cost effectiveness of genetic tests in helping doctors select the most useful HIV drugs with the fewest side effects.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.